65 related articles for article (PubMed ID: 10604735)
1. DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases.
Klonisch T; Logue SE; Hombach-Klonisch S; Vriend J
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892185
[TBL] [Abstract][Full Text] [Related]
2. ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide.
Raghava Kurup R; Oakes EK; Vadlamani P; Nwosu O; Danthi P; Hundley HA
Sci Rep; 2022 Aug; 12(1):13362. PubMed ID: 35922651
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Circulating Biomarkers in Patients with Glioblastoma.
Senhaji N; Squalli Houssaini A; Lamrabet S; Louati S; Bennis S
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806478
[TBL] [Abstract][Full Text] [Related]
4. In search of effective therapies to overcome resistance to Temozolomide in brain tumours.
Bouzinab K; Summers H; Zhang J; Stevens MFG; Moody CJ; Turyanska L; Thomas NR; Gershkovich P; Ashford MB; Vitterso E; Storer LCD; Grundy R; Bradshaw TD
Cancer Drug Resist; 2019; 2(4):1018-1031. PubMed ID: 35582280
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Biomarkers in Gliomas.
Śledzińska P; Bebyn MG; Furtak J; Kowalewski J; Lewandowska MA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638714
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer.
Oatman N; Dasgupta N; Arora P; Choi K; Gawali MV; Gupta N; Parameswaran S; Salomone J; Reisz JA; Lawler S; Furnari F; Brennan C; Wu J; Sallans L; Gudelsky G; Desai P; Gebelein B; Weirauch MT; D'Alessandro A; Komurov K; Dasgupta B
Sci Adv; 2021 Feb; 7(7):. PubMed ID: 33568479
[TBL] [Abstract][Full Text] [Related]
7. Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma.
Richard S; Tachon G; Milin S; Wager M; Karayan-Tapon L
Cancer Med; 2020 Sep; 9(17):6344-6353. PubMed ID: 32666673
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for glioma immunotherapy: the next generation.
Sims JS; Ung TH; Neira JA; Canoll P; Bruce JN
J Neurooncol; 2015 Jul; 123(3):359-72. PubMed ID: 25724916
[TBL] [Abstract][Full Text] [Related]
9. Biology, genetics and imaging of glial cell tumours.
Walker C; Baborie A; Crooks D; Wilkins S; Jenkinson MD
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S90-106. PubMed ID: 22433833
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
Dreyfuss JM; Johnson MD; Park PJ
Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
[TBL] [Abstract][Full Text] [Related]
11. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.
Liu J; Lu H; Ohgaki H; Merlo A; Shen Z
BMC Cancer; 2009 Aug; 9():268. PubMed ID: 19653894
[TBL] [Abstract][Full Text] [Related]
12. Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.
Nakahara Y; Shiraishi T; Okamoto H; Mineta T; Oishi T; Sasaki K; Tabuchi K
Neuro Oncol; 2004 Oct; 6(4):281-9. PubMed ID: 15494095
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases.
Karoui M; Tresallet C; Julie C; Zimmermann U; Staroz F; Brams A; Muti C; Boulard C; Robreau AM; Puy H; Malafosse R; Penna C; Pruvot FR; Thiery JP; Boileau C; Rougier P; Nordlinger B; Radvanyi F; Franc B; Hofmann-Radvanyi H
Br J Cancer; 2004 Mar; 90(6):1230-4. PubMed ID: 15026806
[TBL] [Abstract][Full Text] [Related]
15. The importance of genomic copy number changes in the prognosis of glioblastoma multiforme.
Arslantas A; Artan S; Oner U; Müslümanoğlu H; Durmaz R; Cosan E; Atasoy MA; Başaran N; Tel E
Neurosurg Rev; 2004 Jan; 27(1):58-64. PubMed ID: 12845540
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.
Terada K; Tamiya T; Daido S; Kambara H; Tanaka H; Ono Y; Matsumoto K; Ito S; Ouchida M; Ohmoto T; Shimizu K
J Neurooncol; 2002 Jun; 58(2):107-14. PubMed ID: 12164681
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology.
Fuller CE; Perry A
Brain Pathol; 2002 Jan; 12(1):67-86. PubMed ID: 11770903
[TBL] [Abstract][Full Text] [Related]
18. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas.
Balesaria S; Brock C; Bower M; Clark J; Nicholson SK; Lewis P; de Sanctis S; Evans H; Peterson D; Mendoza N; Glaser MG; Newlands ES; Fisher RA
Br J Cancer; 1999 Dec; 81(8):1371-7. PubMed ID: 10604735
[TBL] [Abstract][Full Text] [Related]
19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
